$20.24
Price
$871M
Market Cap
43.1
P/E Ratio
5.9
Forward P/E
$0.47
EPS (TTM)
—
Dividend Yield
$246M
Cash
$639M
Total Debt
41M
Shares Out
$18.80
$27.64
52-Week Range
Institutional Ownership of PACIRA BIOSCIENCES INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for PACIRA BIOSCIENCES INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for PACIRA BIOSCIENCES INC
6 Months Insider Sentiment
Buy $0
Sell $1.1M
0
Buys
6
Sells
-1.1M
Net
1
Grants
Largest
$398K
Cross
$266K
Cross
$261K
Cross
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 05, 2026 | Lauren Riker | Senior Vice President, Finance | SELL | 1.4K | $24.24 | $34K |
| Dec 31, 2025 | Brendan Teehan | Chief Commercial Officer | GRANT | 402 | $10.76 | $4K |
| Dec 10, 2025 | Shawn Cross | Chief Financial Officer | EXERCISE | 9.1K | $16.45 | $150K |
| Dec 10, 2025 | Shawn Cross | Chief Financial Officer | SELL | 9.1K | $25.14 | $229K |
| Dec 09, 2025 | Shawn Cross | Chief Financial Officer | EXERCISE | 15.9K | $16.45 | $261K |
| Dec 09, 2025 | Shawn Cross | Chief Financial Officer | SELL | 15.9K | $25.03 | $398K |
| Nov 17, 2025 | Jonathan Slonin | Chief Medical Officer | SELL | 4.0K | $24.09 | $95K |
| Nov 10, 2025 | Shawn Cross | Chief Financial Officer | SELL | 12.1K | $22.09 | $266K |
| Sep 04, 2025 | Abraham Ceesay | Director | SELL | 2.4K | $27.19 | $64K |